Ferring B.V.
202Patents
156Active
202Granted
57Portfolio score
Filing activity: Dec 17, 1985 → May 2, 2023 · 29 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5939560A | Inhibitors of DP-mediated processes, compositions and therapeutic methods thereof | Chemistry; Metallurgy | 114 | Expired |
| US5725872A | Composition for foams, notably rectal foams, and foams thus obtained | Human Necessities | 96 | Expired |
| US6201132A | Inhibitors of DP-mediated processes, compositions, and therapeutic methods thereof | Chemistry; Metallurgy | 63 | Expired |
| US5965701A | Kappa receptor opioid peptides | Human Necessities | 63 | Expired |
| US8557281B2 | Water-swellable polymers | Chemistry; Metallurgy | 56 | Active |
| US5922680A | Stabilized composition for oral administration of peptides | Human Necessities | 54 | Expired |
| US6143722A | Heptapeptide oxytocin analogues | Human Necessities | 53 | Expired |
| US5990273A | Synthesis of cyclic peptides | Human Necessities | 50 | Expired |
| US5821230A | GnRH antagonist decapeptides | Human Necessities | 39 | Expired |
| USD701615S1 | Swirling apparatus | General | 38 | Active |
| US5763398A | Nasal administration of desmopressin | Human Necessities | 37 | Expired |
| US5698516A | Biologically active vasopressin analogues | Emerging Cross-Sectional Technologies | 36 | Expired |
| US5047398A | DDAVP antidiuretic and method therefor | Human Necessities | 32 | Expired |
| US6214798A | GnRH antagonists being modified in positions 5 and 6 | Emerging Cross-Sectional Technologies | 32 | Expired |
| US6521644B1 | Compositions for promoting growth | Human Necessities | 29 | Expired |
| US5763405A | Stabilized composition for oral administration of peptides | Human Necessities | 28 | Expired |
| US5925730A | GnRH antagonists | Emerging Cross-Sectional Technologies | 26 | Expired |
| US5780434A | Composition for oral administration of peptides | Human Necessities | 24 | Expired |
| US5985835A | Desmopressin for nocturia, incontinence and enuresis | Chemistry; Metallurgy | 23 | Expired |
| US5763407A | High-purity desmopressin produced in large single batches | Chemistry; Metallurgy | 21 | Expired |
| US7074781B2 | Condensed azepines as vasopressin agonists | Chemistry; Metallurgy | 20 | Expired |
| US6664249B1 | Bicyclic vasopressin agonists | Chemistry; Metallurgy | 20 | Expired |
| US7560429B2 | Orodispersible dosage forms of desmopressin acetate | Human Necessities | 18 | Expired |
| US7094545B2 | Pharmaceutical composition as solid dosage form and method for manufacturing thereof | Human Necessities | 18 | Expired |
| US7022340B2 | Pharmaceutical composition as solid dosage form and method for manufacturing thereof | Human Necessities | 18 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.